Call for Late Breaking Abstracts!

DIA has finally launched the sessions for DIA 2017, but we still need your input!

Do you have a session idea that addresses the targeted topics listed below, chosen as the most timely, noteworthy, and significant for this year's audience?

New this year, the Annual Meeting Program Committee invites you to contribute to the discussion of the latest issues surrounding our industry by submitting a Late Breaking Abstract for consideration. This is your exclusive chance to have your voice heard one last time before we solidify the final program.

To be considered for review, your abstract must focus on and be relevant to one of the specific targeted topics. This Call is not an extension of the general call for sessions.

Submit Late Breaking Abstract

• Targeted Topics

  • Impact of recent changes in government on the health care system and pharmaceutical industry (e.g. US administration, Brexit)
  • Hybrid studies (studies combining secondary data/Real-World data, such as claims or EMR data with primary data such as those collected in registries, surveys, or clinical trials)
  • "Putting the Me in Medicine" (e.g. Collaborative master protocols for research with a focus on precision medicine, especially in oncology)
  • Quality metrics – subsequent to the recent revisions to 11/2016 Quality Metrics draft guidance (e.g. benefits and challenges posed by the newly revised draft guidance for various segments of the pharmaceutical industry, and proposed solutions, different approaches to metrics analysis and implementation, and the quality culture as part of the metrics equation)

  (Abstracts are not automatically accepted for presentation)

  Submit Late Breaking Abstract

• Timeline

  February 7: Call for Late Breaking Abstracts opens
  March 1: Call for Late Breaking Abstracts closes
  Week of March 20: Abstract notification

Registration Rates

Back to DIA 2017

Back to DIAglobal.org